Skip to content
cccskills
FreePublished on GitHub

es-hcm-dose-calcitonin

Calculates salmon calcitonin dose based on patient weight for rapid calcium lowering in hypercalcemia of malignancy. Triggered when a clinician considers rapid calcium lowering and asks about weight‑based calcitonin dosing.

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.1 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Calculate salmon calcitonin dose based on patient weight

STEP 1 — Gather Information

Obtain patient weight in kilograms and confirm clinical indication for rapid calcium lowering (e.g., serum calcium >14 mg/dL or symptomatic severe HCM). Record weight and proceed to dosing decision.

STEP 2 — Rule In / Rule Out

Is the patient a candidate for calcitonin? Yes if severe HCM requiring rapid calcium lowering and planned to start an antiresorptive (bisphosphonate or denosumab); No if mild/moderate HCM or contraindication (e.g., known hypersensitivity). If No, use alternative agents; if Yes, continue to dose selection.

STEP 3 — Classify or Stratify

Select a dose within the 4‑8 units/kg range based on clinical judgment (e.g., 6 units/kg as a typical starting point; consider lower end if renal impairment or frailty). Record the chosen units/kg.

STEP 4 — Decide

Calculate dose per administration: weight (kg) × selected units/kg. Administer intramuscularly or subcutaneously every 6‑12 hours, not exceeding 48‑72 hours total due to tachyphylaxis.

Clinical Guardrails / Mimics / Pitfalls

Do not extend calcitonin beyond 72 hours because tachyphylaxis diminishes effect; avoid using as monotherapy for long‑term HCM control; monitor serum calcium and watch for hypocalcemia, especially in renal insufficiency.

Concrete Clinical Example

A 70‑kg patient with severe HCM (SCa 15.2 mg/dL) needs rapid lowering. Choose 6 units/kg → 420 units per dose. Give 420 units IM q8h for 48 hours, then reassess calcium and transition to bisphosphonate or denosumab.

Source: Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2023, https://doi.org/10.1210/clinem/dgac621

TODO: consider adding scripts/calc.py for the es-hcm-dose-calcitonin calculator

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill